Humanized anti-cd19 antibody formulations

Details Humanized anti-cd19 antibody formulations Humanized anti-cd19 antibody formulations

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 47/32 (2006.01)

Patent

CA 2754266

The present invention provides stable liquid formulations comprising chimeric and humanized versions of anti-CD 19 mouse monoclonal antibodies that may mediate ADCC, CDC, and/or apoptosis for the treatment of B cell diseases and disor-ders.

Cette invention concerne des formulations liquides stables comprenant des versions chimériques et humanisées d'anticorps monoclonaux de souris anti-CD19 aptes à médier l'ADCC, la CDC et/ou l'apoptose pour le traitement des maladies et troubles des cellules B.

Affiliated with

Also associated with

Rating

Humanized anti-cd19 antibody formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Humanized anti-cd19 antibody formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized anti-cd19 antibody formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1713592